ACVRL1 and pulmonary arterial hypertension: The association between ACVRL1 and PAH has been mostly studied starting from a clinical diagnosis of PAH, but Olivieri et al. [52] demonstrated that nine out of sixty-eight (13%) cases selected solely because of the presence of pathogenic ACVRL1 mutations had increased values of pulmonary artery systolic pressure.